MiNDERA Corporation

MiNDERA Corporation

MiNDERA Corporation

MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases.
Type
B2c
Founded
2013
Raised
$14.1M
Follow us
Alexa global traffic share
Latest funding Show all
$12,000,000
Venture capital (Series A) - 2021
Mountain Group Capital Scientific Health Development Partners Rockmont Investments
$1,000,000
Seed fund - 2015
Team Size
1–10
Employees
$12,000,000 Venture capital (Series A)
neurons.AI

Mindera Raises Over $12 Million Series A-2 Financing